Global Pharmaceuticals & Biotech Most Popular Stocks

Allstar Health Brands

Market Cap: US$179.8k

A specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas.

Cresanto Global

Market Cap: ₹15.6m

Does not have significant operations.

GNCC Capital

Market Cap: US$174.1k

Through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils.

Advanced Proteome Therapeutics

Market Cap: CA$205.6k

Through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States.

ViaDerma

Market Cap: US$123.4k

Operates as a specialty pharmaceutical company in the United States.

Ampio Pharmaceuticals

Market Cap: US$121.7k

A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.

Endonovo Therapeutics

Market Cap: US$120.7k

A biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine.

Neovacs

Market Cap: €87.5k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.

Woodbrook Group Holdings

Market Cap: US$99.4k

Provides investment and strategic planning advisory services.

Medicine Man Technologies

Market Cap: US$85.6k

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

Zhengduozhe Technology

Market Cap: US$84.1k

Zhengduozhe Technology, Inc, doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings.

Paion

Market Cap: €71.3k

A specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.

GB Sciences

Market Cap: US$81.4k

A plant-based research and biopharmaceutical drug development company.

Syros Pharmaceuticals

Market Cap: US$79.2k

A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.

MabCure

Market Cap: US$78.1k

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.

Nouveau Life Pharmaceuticals

Market Cap: US$66.6k

A development stage company, engages in the development of nutraceuticals products.

U.S. Stem Cell

Market Cap: US$66.2k

A biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States.

Affymax

Market Cap: US$59.6k

Does not have significant operations.

Immunotech Laboratories

Market Cap: US$57.5k

Develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders.

Bright Green

Market Cap: US$57.3k

Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

Mera Pharmaceuticals

Market Cap: US$53.7k

Focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.

Cannonau

Market Cap: US$48.4k

Engages in the provision of cannabidiol based products.

Medican Enterprises

Market Cap: US$46.5k

A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector.

Plandaí Biotechnology

Market Cap: US$44.9k

Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.

Itoco

Market Cap: US$42.8k

Engages in the processing, production, and distribution of medical cannabis products.

Emergent Health

Market Cap: US$42.7k

Develops and sells regenerative medicine, neutraceuticals, and phytonutritionals.

Oncology Pharma

Market Cap: US$42.5k

An oncology company, develops, manufactures, and commercializes therapeutics.

Sunset Island Group

Market Cap: US$34.4k

Through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States.

Virpax Pharmaceuticals

Market Cap: US$31.2k

A preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders.

Blue Water Ventures International

Market Cap: US$30.3k

Through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments.

China Medicine

Market Cap: US$28.7k

Produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China.

T2 Biosystems

Market Cap: US$28.0k

Engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare.

Curative Biosciences

Market Cap: US$25.8k

Focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol.

Australis Capital

Market Cap: US$25.4k

Operates as a cannabis company.

Petlife Pharmaceuticals

Market Cap: US$22.2k

Engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States.